NEW YORK (GenomeWeb) – Luminex said after the close of the market today that its fourth quarter revenues increased 5 percent year over year driven primarily by strong assay sales.

For the fourth quarter ended Dec. 31, 2014, Luminex reported $58.1 million in revenues compared to $55.2 million in the year-ago period and just below analysts' consensus estimate of $58.3 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Wired reports that 23andMe is trying to bolster its outside collaborations.